yonsa

Churchill Pharmaceuticals required the development of a proprietary brand name for their new prostate cancer treatment, SoluMatrix Abirateron Acetate (SAA). This treatment would directly compete with Janssen’s Zytiga, and Brandsymbol was tasked with creating a viable alternative. Utilizing key points of differentiation, our team developed the name Yonsa®. The name tested well internally/externally, establishing it as an approachable and memorable brand name.